Keywords: لوسمی مزمن لنفوئیدی; Ag; antigen; bnAb; broadly neutralizing anti-HIV Ig; CLL; chronic lymphocytic leukemia; EBV; Epstein Barr virus; GBM; glomerular basement membrane; GN; glomerulonephritis; GP; Goodpasture; GPS; GP syndrome; HC; heavy chain; HCDR3; heavy chain complementar
مقالات ISI لوسمی مزمن لنفوئیدی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Co-culture systems; Mouse models;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Lenalidomide; Clinical efficacy; Immune activation; Microenvironment; Response prediction
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Immunophenotyping; Cytogenetics; Staging; Prognosis;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Non-Hodgkin lymphoma; Elderly;
Keywords: لوسمی مزمن لنفوئیدی; bendamustine; chronic lymphocytic leukemia; economic evaluation; obinutuzumab; ofatumumab; rituximab;
Keywords: لوسمی مزمن لنفوئیدی; Gene mutations; Chronic lymphocytic leukemia; Biology and prognosis;
Keywords: لوسمی مزمن لنفوئیدی; ALK; anaplastic lymphoma kinase; ALL; acute lymphoblastic leukemia; CLL; chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; CNS; central nervous system; CRC; colorectal cancer; DTC; differentiated thyroid carcinoma; DUSP; dual specificity ph
Keywords: لوسمی مزمن لنفوئیدی; AML; Acute myeloid leukemia; CAS; Cellular apoptosis susceptibility; CLL; Chronic lymphocytic leukemia; CML; Chronic myeloid leukemia; CRM1; Chromosome region maintenance 1; NES; Nuclear export signal; NF-κB; Nuclear factor-κB; NLS; Nuclear localizing s
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Choice of therapy; Chemoimmunotherapy; Kinase inhibitors;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Cyclin-dependent kinase inhibitors; Targeted therapy; Alvocidib (Flavopiridol);
Keywords: لوسمی مزمن لنفوئیدی; chronic lymphocytic leukemia; Merkel cell carcinoma
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Merkel cell polyomavirus; Overall survival; Polymerase chain reaction; Prognostic factors
Keywords: لوسمی مزمن لنفوئیدی; Alemtuzumab; Chronic lymphocytic leukemia; Fludarabine; Minimal residual disease; Small lymphocytic lymphoma
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Venous thromboembolism; Deep vein thrombosis; Pulmonary embolism;
Keywords: لوسمی مزمن لنفوئیدی; AML; acute myeloid leukemia; CI; Confidence Interval; CLL; chronic lymphocytic leukemia; CML; chronic myeloid leukemia; IRB; Institutional Review Board; MDS; myelodysplastic syndrome; Non-CLL; non-chronic lymphocytic leukemia; OR; odds ratio; RADRUE; Real
Keywords: لوسمی مزمن لنفوئیدی; Hematologic malignancy; Hypereosinophilia; Hypereosinophilic syndrome; Lymphoma; Leukemia; AICL; Angioimmunoblastic T-cell leukemia; AML; Acute myelogenous leukemia; ATLL; Adult T-cell lymphoma/leukemia; BE; Blood eosinophilia; CEL; Chronic eosinophilic l
Keywords: لوسمی مزمن لنفوئیدی; ALL; acute lymphoblastic leukemia; AML; acute myelogenous leukemia; CLL; chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; HL; Hodgkin lymphoma; HR; hazard ratio; IOM; Institute of Medicine; ICU; intensive care unit; MM; multiple myeloma; N
Keywords: لوسمی مزمن لنفوئیدی; ABT-199; delecja 17p; ibrutinib; idelalisib; przewlekła białaczka limfocytowa; wiek biologicznyABT-199; 17p deletion; Ibrutinib; Idelalisib; Chronic lymphocytic leukemia; Biological age
Keywords: لوسمی مزمن لنفوئیدی; chronic lymphocytic leukemia; immunosuppression; malignant melanoma; Mohs micrographic surgeryBCC, basal cell carcinoma; CI, confidence interval; CLL, chronic lymphocytic leukemia; NHL, non-Hodgkin lymphoma; NMSC, nonmelanoma skin cancer; REP, Rochester E
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Elderly; Functional status; Geriatric assessment; Alkylators; Purine analogs; Anti-CD20 monoclonal antibodies; Immunomodulatory agents; Bruton's tyrosine kinase inhibitors; PI3 kinase inhibitors;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Rituximab; Cyclophosphamide; Fludarabine; Meta-analysis
Keywords: لوسمی مزمن لنفوئیدی; BM; bone marrow; CKD; chronic kidney disease; CLL; chronic lymphocytic leukemia; eGFR; estimated glomerular filtration rate; GN; glomerulonephritis; MGRS; monoclonal gammopathy of renal significance; MGUS; monoclonal gammopathy of undetermined significanc
Keywords: لوسمی مزمن لنفوئیدی; Cancer Genomics Consortium; Cancer cytogenomic microarray; Chronic lymphocytic leukemia; Myelodysplastic syndrome; Renal epithelial tumor;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Duvelisib; Ibrutinib; Idelalisib; Monoclonal antibodies; Obinutuzumab; Small molecule inhibitors; Venetoclax;
Keywords: لوسمی مزمن لنفوئیدی; ABL; Abelson; ALL; acute lymphocytic leukemia; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; BC; blast crisis; BCR; breakpoint cluster region; BMP; bone morphogenetic protein; CBP; CREB-binding protein; CDK; cyclin dependent kinase; CEBP
Keywords: لوسمی مزمن لنفوئیدی; Umbilical cord blood transplantation; Chronic lymphocytic leukemia; Reduced-intensity conditioning regimen;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Next-generation sequencing; Immunogenetics; Clonal evolution; B-cell receptor signaling;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Total body irradiation; Conditioning; Myeloablative
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Stage progression; Gene expression profile; Cytokine profile; Transcription factors; SETD8; CSNK1E; SDF-1/CXCL12;
Keywords: لوسمی مزمن لنفوئیدی; Hematopoietic cell transplantation; Clinical Trials Network; Clinical trials; Graft-versus-host disease; Acute myeloid leukemia; Acute lymphocytic leukemia; Chronic lymphocytic leukemia; T cell lymphoma; Hemaphogocytic lymphohistiocytosis; Crohn's disease
Keywords: لوسمی مزمن لنفوئیدی; transplantacja komórek krwiotwórczych; marginalna choroba resztkowa; przewlekÅa biaÅaczka limfocytowa; Hematopoietic Stem Cell Transplantation; Minimal Residual Disease; Chronic Lymphocytic Leukemia;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Microenviroment; Mouse models; Cytoskeleton
Keywords: لوسمی مزمن لنفوئیدی; ADR; adverse drug reaction; AE; adverse event; AML; acute myeloid leukemia; ALL; acute lymphoblastic leukemia; APL; acute promyelocytic leukemia; APTT; activated partial thromboplastin time; AT; antithrombin; CLL; chronic lymphocytic leukemia; CML; chroni
Keywords: لوسمی مزمن لنفوئیدی; AIHA; autoimmune hemolytic anemia; ASH; American Society of Hematology; CLL; chronic lymphocytic leukemia; CMV; cytomegalovirus; CVID; common variable immunodeficiency; GPRD; General Practice Research Database; DIC; disseminated intravascular coagulation;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Reduced-intensity conditioning; Myeloablative allogeneic hematopoietic cell transplantation; Outcomes
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; cytogenetic; fluorescence in situ hybridization; validation; population-based
Keywords: لوسمی مزمن لنفوئیدی; Aggressive variant of CLL; Chronic lymphocytic leukemia; CNS demyelination; Neurological paraneoplastic syndrome; Small lymphocytic lymphoma;
Keywords: لوسمی مزمن لنفوئیدی; Chromosomal aberration; chromosomal mosaic; chronic lymphocytic leukemia; cancer precursor condition; cytogenetics
Keywords: لوسمی مزمن لنفوئیدی; cancer; chemotherapy; cutaneous reactions; cytotoxic therapy; drug hypersensitivity; rash; 5-FU; 5-flurouracil; CLL; chronic lymphocytic leukemia; HFS; hand-foot syndrome; NHL; non-Hodgkin lymphoma; NSCLC; non-small cell lung carcinoma;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Allogeneic hematopoietic stem cell transplantation; Novel substances; High-risk patients; GvL; GvHD;
Keywords: لوسمی مزمن لنفوئیدی; Chronic Lymphocytic Leukemia; Relapse; Lenalidomide; Tumor flare; Maintenance;
Keywords: لوسمی مزمن لنفوئیدی; B2M; beta 2 microglobulin; CAR; cyclophophamide, alvocidib, rituximab; CDK; cyclin-dependent kinase; CLL; chronic lymphocytic leukemia; CR; complete response; CRS; cytokine release syndrome; DLT; dose limiting toxicity; ECOG; Eastern Cooperative Oncology
Keywords: لوسمی مزمن لنفوئیدی; AML; acute myelogenous leukemia; BD; 1,3-butadiene; CLL; chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; EU; European Union; DMDTC; dimethyldithiocarbamate; HIT; high-intensity task; mle; maximum likelihood estimate; MoA; mode of action;
Keywords: لوسمی مزمن لنفوئیدی; AML; acute myeloid leukemia; CAM-DR; cell adhesion-mediated drug resistance; CCP; charge-conversion polymer; CLL; chronic lymphocytic leukemia; CNS; central nervous system; CSC; cancer stem cell; EGFR; epidermal growth factor receptor; EPR; enhanced perme
Keywords: لوسمی مزمن لنفوئیدی; Genetic analysis; Chronic lymphocytic leukemia; Clinical aspect; SRSF2
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Ionizing radiation; 2nd cancer risks; SEER
Keywords: لوسمی مزمن لنفوئیدی; Recombinant activated factor VII; oral bleeding; full-mouth extraction; chronic lymphocytic leukemia; small lymphocytic lymphomaB-CLL/SLL, B-cell lymphocytic leukemia/small lymphocytic lymphoma; CD, Cluster of differentiation; FFP, Fresh frozen plasma; PL
Keywords: لوسمی مزمن لنفوئیدی; Blood lipid profiles; Cholesterol levels; Chronic lymphocytic leukemia;
Signification of protein p-53 isoforms and immune therapeutic success in chronic lymphocytic leukemia
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; P-53 protein isoform; Aurora kinase; m-TOR; Anti-PD therapeutic agents;